Hot Alert: American Woodmark Corp. (NASDAQ:AMWD), Xenoport, Inc. (NASDAQ:XNPT), Pilgrim’s Pride Corporation (NASDAQ:PPC), PHH Corporation (NYSE:PHH), Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Technology Stocks News 16

American Woodmark Corporation (NASDAQ:AMWD) announced results for its second fiscal quarter ended October 31, 2014. Net sales for the second fiscal quarter increased 14% to $217.7 million compared with the same quarter of the prior fiscal year. Net sales for the first six months of the current fiscal year increased 17% to $429.6 million from the comparable period of the prior fiscal year. The Company experienced growth in both the remodeling and new construction channels during the second quarter of fiscal year 2015, with new construction growth exceeding 20%. American Woodmark Corp. (NASDAQ:AMWD) belongs to Consumer Goods sector. Its net profit margin is 3.00% and weekly performance is 1.44%. On last trading day company shares ended up $40.92. American Woodmark Corp. (NASDAQ:AMWD) distance from 50-day simple moving average (SMA50) is 5.05%.

XenoPort, Inc. (NASDAQ:XNPT) announced that it presented at the 2014 Credit Suisse Healthcare Conference in Phoenix, Arizona on Wednesday, November 12, 2014. Xenoport, Inc. (NASDAQ:XNPT) shares increased 2.26% in last trading session and ended the day at $8.60. XNPT Gross Margin is 94.80% and its return on assets is -40.50%. Xenoport, Inc. (NASDAQ:XNPT) quarterly performance is 66.34%.

Pilgrim’s Pride Co. (NYSE:PPC) CEO William W. Lovette sold 24,250 shares of Pilgrim’s Pride Co. stock in a transaction that occurred on Tuesday, November 4th. The stock was sold at an average price of $30.30, for a total transaction of $734,775.00. Following the transaction, the chief executive officer now directly owns 186,750 shares of the company’s stock, valued at approximately $5,658,525. On 25 November, Pilgrim’s Pride Corporation (NASDAQ:PPC) shares increased 0.54% and was closed at $31.54. PPC EPS growth in last 5 year was 16.50%. Pilgrim’s Pride Corporation (NASDAQ:PPC) year to date (YTD) performance is 94.09%.

Shares of PHH (NYSE:PHH) have earned an average recommendation of “Hold” from the nine brokerages that are covering the company, American Banking News.com reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $25.06. PHH Corporation (NYSE:PHH) ended the last trading day at $23.28. Company weekly volatility is calculated as 2.28% and price to cash ratio as 0.82. PHH Corporation (NYSE:PHH) showed a weekly performance of -1.23%.

Jazz Pharmaceuticals plc – (NASDAQ:JAZZ) CMO Jeffrey K. Tobias unloaded 4,598 shares of the stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $170.12, for a total transaction of $782,211.76. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) shares moved down -0.01% in last trading session and ended the day at $170.43. JAZZ Gross Margin is 89.40% and its return on assets is 1.10%. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) quarterly performance is 4.49%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone